CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven molecular ...

MedAxiom and AccuCode AI today announced the launch of AccuCode CV, an artificial intelligence (AI)-augmented cardiovascular ...

Cardiovascular disease is the leading cause of death worldwide. The primary objective of therapies is to reduce the incidence of major adverse cardiovascular events (MACE). The leading class of drugs ...

Please provide your email address to receive an email when new articles are posted on . Geographic health disparities are multifactorial and present barriers to optimal cardio-obstetrics care.

Johnson & Johnson sealed its biggest deal in six years by acquiring cardiovascular med tech company Abiomed for $16.6 billion, the company announced Tuesday. Abiomed, which develops heart pumps, will ...

New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...

Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of ...

Jun 10, 2025, 8:35 AM ETCardio Diagnostics Holdings, Inc. (CDIO) “We are proud to support this important innovation from the University of Iowa ecosystem,” said Marie Kerbeshian, Ph.D., Executive ...